Teladoc Health Inc $ 102.8 0 (0%)
Volume:
1,365,791
Avg Vol (1m):
1,196,200
Market Cap $:
7.48 Bil
Enterprise Value $:
7.45 Bil
P/E (TTM):
0.00
P/B:
7.49
Financial Strength | 6/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 1.06 | ||
| Equity-to-Asset | 0.63 | ||
| Debt-to-Equity | 0.47 | ||
| Debt-to-EBITDA | -13.79 | ||
| Piotroski F-Score | 4 | ||
| Altman Z-Score | 7.89 | ||
| Beneish M-Score | -2.48 | ||
| WACC vs ROIC | |||
Profitability Rank | 3/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -14.84 | ||
| Net Margin % | -20.15 | ||
| ROE % | -10.39 | ||
| ROA % | -6.76 | ||
| ROC (Joel Greenblatt) % | -289.65 | ||
| 3-Year Revenue Growth Rate | 17.8 | ||
| 3-Year EBITDA Growth Rate | 43.3 | ||
| 3-Year EPS without NRI Growth Rate | 20.4 |
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 7.49 | ||
| PS Ratio | 14.11 | ||
| Price-to-Free-Cash-Flow | 2056 | ||
| Price-to-Operating-Cash-Flow | 521.83 | ||
| EV-to-EBIT | -96.66 | ||
| EV-to-EBITDA | -221.21 | ||
| EV-to-Revenue | 14.35 | ||
| Current Ratio | 6.55 | ||
| Quick Ratio | 6.55 | ||
| Days Sales Outstanding | 37.7 | ||
| Days Payable | 13.09 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.3 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 270.53 | ||
| Price-to-Median-PS-Value | 1.59 | ||
| Earnings Yield (Greenblatt) % | -1.03 |